Provided by Tiger Fintech (Singapore) Pte. Ltd.

Capstone Therapeutics Corp

2.16
-0.0500-2.26%
Volume:113.11K
Turnover:241.92K
Market Cap:11.21M
PE:-0.06
High:2.43
Open:2.09
Low:1.80
Close:2.21
Loading ...

Company Profile

Company Name:
Capstone Therapeutics Corp
Exchange:
NASDAQ
Establishment Date:
1987
Employees:
38
Office Location:
5141 W. 122nd Street,Alsip,Illinois,United States
Zip Code:
60803
Fax:
- -
Introduction:
Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

Directors

Name
Position
Matthew E. Lipman
Chief Executive Officer and Director
Michael M. Toporek, III
Chairman
Charles Dana
Lead Independent Director
Elwood D. Howse, Jr.
Director
Fredric J. Feldman
Director
Gordon Strout
Director
John M. Holliman, III
Director

Shareholders

Name
Position
Matthew E. Lipman
Chief Executive Officer and Director
Edward Schultz
Chief Financial Officer